Mini Theta Burst TMS to Promote Brain Plasticity Indexed by fMRI

Mini Theta Burst TMS to Promote Brain Plasticity Indexed by fMRI

Brief description of study

Non-invasive transcranial magnetic stimulation (TMS) is now FDA-approved for the treatment of major depressive disorder (MDD). However, there is growing evidence that the targeting strategy for delivering TMS treatment would yield superior clinical outcomes if it were more tailored to individual neuroanatomy. In this study, we plan to examine whether functional MRI-guided TMS might be more effective than traditional methods at temporarily influencing neural circuit communication. If this is true, future studies may utilize these methods to yield an even greater leap forward in promoting optimal clinical outcomes using full doses of TMS for treatment.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Major Depressive Disorder
  • Age: - 99 Years
  • Gender: All


Updated on 16 Jun 2021. Study ID: 825761

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center